Clene holder sells 95,473 shares in open-market trades

Clene Inc. insider filings show that shares held indirectly for investor Ugwumba Chidozie through SymBiosis II, LLC were sold in two open-market transactions.

Rhea-AI Filing Summary

Clene Inc. insider filings show that shares held indirectly for investor Ugwumba Chidozie through SymBiosis II, LLC were sold in two open-market transactions. The entity sold a total of 95,473 shares of common stock at prices of $6.20 and $6.75 per share, leaving 103,417 shares indirectly held after the most recent sale.

Insights

Equity markets analyst

Large holder associated with Clene reduced its position via open-market sales.

A ten percent owner of Clene Inc., through SymBiosis II, LLC, executed open-market sales totaling 95,473 common shares at prices between $6.20 and $6.75. These are discretionary sales, not option exercises or tax withholdings.

Following the transactions, 103,417 shares remain indirectly held, indicating the investor kept a meaningful stake. The filing does not reference a Rule 10b5‑1 trading plan, so timing appears discretionary based on the provided data.

Insider Trade Summary

Net Seller: 95,473 shares

Net Sell 2 txns

Insider Ugwumba Chidozie

Role 10% Owner

Sold 95,473 shs ($604K)

Type	Security	Shares	Price	Value
Sale	Common Stock	73,296	$6.20	$454K
Sale	Common Stock	22,177	$6.75	$150K

Holdings After Transaction: Common Stock — 103,417 shares (Indirect, By SymBiosis II, LLC)

Key Figures

Total shares sold: 95,473 shares Sale price 1: $6.75 per share Sale price 2: $6.20 per share +3 more

6 metrics

Total shares sold 95,473 shares Net shares sold across two open-market transactions

Sale price 1 $6.75 per share Price for 22,177-share sale on May 11, 2026

Sale price 2 $6.20 per share Price for 73,296-share sale on May 12, 2026

Shares after latest sale 103,417 shares Indirectly owned through SymBiosis II, LLC after May 12, 2026

First transaction size 22,177 shares Common stock sold May 11, 2026, indirect ownership

Second transaction size 73,296 shares Common stock sold May 12, 2026, indirect ownership

Key Terms

open-market sale, indirect ownership, ten percent owner, non-derivative

4 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

indirect ownership financial

"direct_or_indirect": "I", "nature_of_ownership": "By SymBiosis II, LLC""

ten percent owner financial

""is_ten_percent_owner": 1"

non-derivative financial

""transaction_type": "non-derivative""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ugwumba Chidozie report in this Clene (CLNN) Form 4 filing?

The Form 4 reports that shares of Clene common stock held indirectly for Ugwumba Chidozie through SymBiosis II, LLC were sold in the open market. Two transactions reduced the indirect position but left a remaining stake of 103,417 shares after the latest sale.

How many Clene (CLNN) shares were sold in the reported transactions?

The filing shows total sales of 95,473 Clene common shares. One transaction on May 11 involved 22,177 shares, and another on May 12 involved 73,296 shares. Both transactions were coded as open-market or private sales of non-derivative common stock.

At what prices were Clene (CLNN) shares sold in the Form 4 transactions?

The Form 4 discloses sale prices of $6.75 and $6.20 per share. The 22,177-share sale on May 11 occurred at $6.75, while the 73,296-share sale on May 12 occurred at $6.20, reflecting open-market pricing across two consecutive trading days.

How many Clene (CLNN) shares does the reporting person hold after these sales?

After the most recent transaction, the filing states that 103,417 Clene common shares are indirectly owned. These shares are held through SymBiosis II, LLC, reflecting the remaining position following the reported open-market sales totaling 95,473 shares of common stock.

Are the Clene (CLNN) Form 4 transactions direct or indirect holdings?

All reported transactions involve indirect ownership. The Form 4 marks each as "I" for indirect, with the nature of ownership specified as "By SymBiosis II, LLC." This means the sales and remaining holdings are attributed to that entity rather than to direct personal holdings.

What type of transaction code is used in this Clene (CLNN) Form 4?

Both entries use transaction code "S," which the filing describes as a sale in an open-market or private transaction. The code applies to non-derivative common stock, distinguishing these trades from option exercises, conversions, gifts, or tax-withholding related movements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 06:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ugwumba Chidozie

(Last) (First) (Middle)

609 SW 8TH STREET

SUITE 510

(Street)

BENTONVILLE ARKANSAS 72712

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2013

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/11/2026		S		22,177	D	$6.75	176,713	I	By SymBiosis II, LLC
Common Stock	05/12/2026		S		73,296	D	$6.2	103,417	I	By SymBiosis II, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

As a result of the transaction reported within this Form 4, the Reporting Person's beneficial ownership has fallen below 10% of the outstanding shares of Common Stock of the Issuer. Accordingly, the Reporting Person is no longer subject to Section 16 of the Securities Exchange Act of 1934 with respect to the Issuer.

	/s/ Chidozie Ugwumba	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)